Annual CFI
-$1.26 M
-$1.23 M-4128.86%
30 June 2024
Summary:
Renovaro Biosciences annual cash flow from investing activities is currently -$1.26 million, with the most recent change of -$1.23 million (-4128.86%) on 30 June 2024. During the last 3 years, it has fallen by -$1.21 million (-2477.10%). RENB annual CFI is now -219.68% below its all-time high of $1.05 million, reached on 01 June 2016.RENB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
+$53.40 K+100.00%
30 September 2024
Summary:
Renovaro Biosciences quarterly cash flow from investing activities is currently $0.00, with the most recent change of +$53.40 thousand (+100.00%) on 30 September 2024. Over the past year, it has increased by +$1.06 million (+100.00%). RENB quarterly CFI is now -100.00% below its all-time high of $4.78 million, reached on 01 March 2018.RENB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$202.30 K
+$1.06 M+83.95%
30 September 2024
Summary:
Renovaro Biosciences TTM cash flow from investing activities is currently -$202.30 thousand, with the most recent change of +$1.06 million (+83.95%) on 30 September 2024. Over the past year, it has increased by +$885.30 thousand (+81.40%). RENB TTM CFI is now -105.26% below its all-time high of $3.85 million, reached on 01 December 2018.RENB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4128.9% | +100.0% | +81.4% |
| 3 y3 years | -2477.1% | 0.0% | -366.1% |
| 5 y5 years | -75.8% | +100.0% | +2.9% |
RENB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | <-9999.0% | at low | +100.0% | +84.0% | ||
| 5 y | 5 years | <-9999.0% | at low | +100.0% | +84.0% | ||
| alltime | all time | -219.7% | +35.4% | -100.0% | +100.0% | -105.3% | +96.2% |
Renovaro Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | -$202.30 K(-83.9%) |
| June 2024 | -$1.26 M(+4128.9%) | -$53.40 K(-41.7%) | -$1.26 M(+3.9%) |
| Mar 2024 | - | -$91.60 K(+59.9%) | -$1.21 M(+8.2%) |
| Dec 2023 | - | -$57.30 K(-94.6%) | -$1.12 M(+3.1%) |
| Sept 2023 | - | -$1.06 M(>+9900.0%) | -$1.09 M(+3562.0%) |
| June 2023 | -$29.80 K(+473.1%) | - | - |
| June 2023 | - | -$6100.00(<-9900.0%) | -$29.70 K(+25.8%) |
| Mar 2023 | - | $0.00(-100.0%) | -$23.60 K(0.0%) |
| Dec 2022 | - | -$23.60 K(<-9900.0%) | -$23.60 K(<-9900.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2022 | -$5200.00(-89.4%) | $0.00(0.0%) | -$5200.00(-88.0%) |
| Mar 2022 | - | $0.00(0.0%) | -$43.40 K(0.0%) |
| Dec 2021 | - | $0.00(-100.0%) | -$43.40 K(-19.8%) |
| Sept 2021 | - | -$5200.00(-86.4%) | -$54.10 K(+10.6%) |
| June 2021 | -$48.90 K(-73.5%) | -$38.20 K(<-9900.0%) | -$48.90 K(+131.8%) |
| Mar 2021 | - | $0.00(-100.0%) | -$21.10 K(-66.4%) |
| Dec 2020 | - | -$10.70 K(<-9900.0%) | -$62.80 K(-45.8%) |
| Sept 2020 | - | $0.00(-100.0%) | -$115.80 K(-37.2%) |
| June 2020 | -$184.50 K(-74.3%) | -$10.40 K(-75.1%) | -$184.40 K(+17.1%) |
| Mar 2020 | - | -$41.70 K(-34.5%) | -$157.50 K(-24.4%) |
| Dec 2019 | - | -$63.70 K(-7.1%) | -$208.40 K(-56.3%) |
| Sept 2019 | - | -$68.60 K(-515.8%) | -$477.10 K(-33.4%) |
| June 2019 | -$716.70 K(+24.5%) | $16.50 K(-117.8%) | -$716.70 K(-30.4%) |
| Mar 2019 | - | -$92.60 K(-72.1%) | -$1.03 M(-126.8%) |
| Dec 2018 | - | -$332.40 K(+7.9%) | $3.85 M(-684.7%) |
| Sept 2018 | - | -$308.20 K(+3.8%) | -$657.80 K(+14.2%) |
| June 2018 | -$575.70 K | -$297.00 K(-106.2%) | -$575.80 K(+21.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $4.78 M(-198.9%) | -$474.90 K(-91.0%) |
| Dec 2017 | - | -$4.84 M(+2038.1%) | -$5.26 M(+1145.3%) |
| Sept 2017 | - | -$226.20 K(+15.3%) | -$422.30 K(+115.3%) |
| June 2017 | -$196.10 K(-118.6%) | -$196.10 K(<-9900.0%) | -$196.10 K(<-9900.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2016 | $1.05 M(+7.8%) | $0.00(0.0%) | $1.05 M(0.0%) |
| Mar 2016 | - | $0.00(0.0%) | $1.05 M(-65.8%) |
| Dec 2015 | - | $0.00(-100.0%) | $3.08 M(+188.6%) |
| Sept 2015 | - | $1.05 M(-48.1%) | $1.07 M(+125.6%) |
| June 2015 | $976.50 K(-150.0%) | - | - |
| Mar 2015 | - | $2.03 M(-200.8%) | $473.40 K(-124.3%) |
| Dec 2014 | -$1.95 M(<-9900.0%) | -$2.01 M(-1627.1%) | -$1.95 M(-2685.4%) |
| Sept 2014 | - | $131.90 K(-59.6%) | $75.50 K(-233.9%) |
| June 2014 | - | $326.30 K(-182.4%) | -$56.40 K(-85.3%) |
| Mar 2014 | - | -$395.90 K(-3099.2%) | -$382.70 K(-2999.2%) |
| Dec 2013 | - | $13.20 K(>+9900.0%) | $13.20 K(>+9900.0%) |
| Sept 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2012 | - | $0.00(0.0%) | -$4800.00(-63.6%) |
| June 2012 | - | $0.00(0.0%) | -$13.20 K(0.0%) |
| Mar 2012 | -$13.20 K(0.0%) | $0.00(-100.0%) | -$13.20 K(0.0%) |
| Dec 2011 | -$13.20 K | -$4800.00(-42.9%) | -$13.20 K(+57.1%) |
| Sept 2011 | - | -$8400.00(<-9900.0%) | -$8400.00(<-9900.0%) |
| June 2011 | - | $0.00 | $0.00 |
FAQ
- What is Renovaro Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Renovaro Biosciences?
- What is Renovaro Biosciences annual CFI year-on-year change?
- What is Renovaro Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly CFI year-on-year change?
- What is Renovaro Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Renovaro Biosciences?
- What is Renovaro Biosciences TTM CFI year-on-year change?
What is Renovaro Biosciences annual cash flow from investing activities?
The current annual CFI of RENB is -$1.26 M
What is the all time high annual CFI for Renovaro Biosciences?
Renovaro Biosciences all-time high annual cash flow from investing activities is $1.05 M
What is Renovaro Biosciences annual CFI year-on-year change?
Over the past year, RENB annual cash flow from investing activities has changed by -$1.23 M (-4128.86%)
What is Renovaro Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of RENB is $0.00
What is the all time high quarterly CFI for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly cash flow from investing activities is $4.78 M
What is Renovaro Biosciences quarterly CFI year-on-year change?
Over the past year, RENB quarterly cash flow from investing activities has changed by +$1.06 M (+100.00%)
What is Renovaro Biosciences TTM cash flow from investing activities?
The current TTM CFI of RENB is -$202.30 K
What is the all time high TTM CFI for Renovaro Biosciences?
Renovaro Biosciences all-time high TTM cash flow from investing activities is $3.85 M
What is Renovaro Biosciences TTM CFI year-on-year change?
Over the past year, RENB TTM cash flow from investing activities has changed by +$885.30 K (+81.40%)